{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:51:38Z","timestamp":1760885498880},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.ijantimicag.2010.11.006","type":"journal-article","created":{"date-parts":[[2010,12,4]],"date-time":"2010-12-04T09:41:09Z","timestamp":1291455669000},"page":"S46-S49","source":"Crossref","is-referenced-by-count":11,"special_numbering":"S2","title":["Aminoglycoside-containing antibiotic combinations for the treatment of bacterial endocarditis: an evidence-based approach"],"prefix":"10.1016","volume":"36","author":[{"given":"Leonard","family":"Leibovici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2010.11.006_bib0005","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/bmj.38028.520995.63","article-title":"Beta lactam monotherapy versus beta lactam\u2013aminoglycoside combination therapy for treating sepsis","volume":"328","author":"Paul","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2010.11.006_bib0010","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/597031","article-title":"Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic","volume":"48","author":"Cosgrove","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.006_bib0015","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.006_bib0020","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1161\/CIRCULATIONAHA.105.165563","volume":"111","author":"Baddour","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijantimicag.2010.11.006_bib0025","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/jac\/dkh474","article-title":"Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy","volume":"54","author":"Elliott","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.006_bib0030","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ehj.2003.11.008","article-title":"Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European Society of Cardiology","volume":"25","author":"Horstkotte","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijantimicag.2010.11.006_bib0035","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jama.286.7.821","article-title":"Comparison of evidence of treatment effects in randomized and nonrandomized studies","volume":"286","author":"Ioannidis","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2010.11.006_bib0040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.idc.2009.01.002","article-title":"Systematic reviews and meta-analyses in infectious diseases: how are they done and what are their strengths and limitations?","volume":"23","author":"Leibovici","year":"2009","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijantimicag.2010.11.006_bib0045","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1086\/515038","article-title":"Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group","volume":"27","author":"Sexton","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.006_bib0050","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-125-12-199612150-00005","article-title":"Effectiveness of cloxacillin with and without gentamicin in short-term therapy for rightsided Staphylococcus aureus endocarditis. A randomized, controlled trial","volume":"125","author":"Ribera","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2010.11.006_bib0055","doi-asserted-by":"crossref","first-page":"496","DOI":"10.7326\/0003-4819-97-4-496","article-title":"Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study","volume":"97","author":"Korzeniowski","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2010.11.006_bib0060","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7326\/0003-4819-90-5-789","article-title":"Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers","volume":"90","author":"Abrams","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2010.11.006_bib0065","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1128\/AAC.23.1.36","article-title":"Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin","volume":"23","author":"Coppens","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.006_bib0070","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/jac\/dkl044","article-title":"The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials","volume":"57","author":"Falagas","year":"2006","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791000467X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791000467X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T11:52:08Z","timestamp":1544097128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485791000467X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":14,"alternative-id":["S092485791000467X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.11.006","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}